Results of a phase I study investigating vaccines for treatment of Waldenstrom Macroglobulinemia.
Home / Resource Library / Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial